Cognitive performance, neuropsychiatric symptoms, and cerebrospinal fluid viral control following programmatic switch from efavirenz-based to dolutegravir-based antiretroviral therapy in South Africa (CONNECT): a prospective cohort study.

Journal: The lancet. HIV

Publication Year: 

Authors & Co-authors:  Nightingale Sam S Dreyer Anna J AJ Thomas Kevin G F KGF van Zyl Gert G Decloedt Eric E Naude Petrus J W PJW Orrell Catherine C Sinxadi Phumla P Winston Alan A Khoo Saye S

Simulating therapeutic drug monitoring results for dose individualisation to maintain investigator blinding in a randomised controlled trial.

Journal: Trials

Publication Year: 2018

Authors & Co-authors:  Lesosky Maia M Joska John J Decloedt Eric E

Abacavir dosing in neonates from birth to 3 months of life: a population pharmacokinetic modelling and simulation study.

Journal: The lancet. HIV

Publication Year: 2022

Authors & Co-authors:  Bekker Adrie A Capparelli Edmund V EV Violari Avy A Cotton Mark F MF Cababasay Mae M Wang Jiajia J Mathiba Ruth R Wiesner Lubbe L Wiznia Andrew A Samson Pearl P

Blood and cerebrospinal fluid biomarker changes in patients with HIV-associated neurocognitive impairment treated with lithium: analysis from a randomised placebo-controlled trial.

Journal: Journal of neurovirology

Publication Year: 2023

Authors & Co-authors:  Thela Lindokuhle L Decloedt Eric E Zetterberg Henrik H Gisslén Magnus M Lesosky Maia M Gleich Melanie M Koutsilieri Eleni E Scheller Carsten C Hye Abdul A Joska John J